Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher P Austin

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Journal of Medicinal Chemistry|September 19, 2009
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasisGanesha Rai, Ahmed A Sayed, Wendy A Lea, et al.
Nature Biotechnology|February 24, 2021
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2Ruili Huang, Miao Xu, Hu Zhu, et al.
Journal of Medicinal Chemistry|November 14, 2009
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatBBryan T Mott, Rafaela S Ferreira, Anton Simeonov, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 2019
The NIH Blueprint for Neuroscience Research Seeks Community Input on Future Neuroscience InvestmentsMeghan C Mott, Christopher P Austin, Diana W Bianchi, et al.
The Journal of Biological Chemistry|October 5, 2012
δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disordersMiao Xu, Ke Liu, Manju Swaroop, et al.
Environmental Health Perspectives|November 3, 2015
Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical ResearchGill Langley, Christopher P Austin, Anil K Balapure, et al.
Clinical and Translational Science|August 11, 2017
Future of Rare Diseases Research 2017-2027: An IRDiRC PerspectiveChristopher P Austin, Christine M Cutillo, Lilian P L Lau, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activationYuli Xie, ShiXian Deng, Craig J Thomas, et al.
Scientific Reports|July 12, 2014
Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathwayRuili Huang, Srilatha Sakamuru, Matt T Martin, et al.
Genomics|May 31, 2002
Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expressionCarina P Tan, Hideki Sano, Hisashi Iwaasa, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Journal of Medicinal Chemistry|September 19, 2009
Structure mechanism insights and the role of nitric oxide donation guide the development of oxadiazole-2-oxides as therapeutic agents against schistosomiasisGanesha Rai, Ahmed A Sayed, Wendy A Lea, et al.
Nature Biotechnology|February 24, 2021
Biological activity-based modeling identifies antiviral leads against SARS-CoV-2Ruili Huang, Miao Xu, Hu Zhu, et al.
Journal of Medicinal Chemistry|November 14, 2009
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatBBryan T Mott, Rafaela S Ferreira, Anton Simeonov, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 1, 2019
The NIH Blueprint for Neuroscience Research Seeks Community Input on Future Neuroscience InvestmentsMeghan C Mott, Christopher P Austin, Diana W Bianchi, et al.
The Journal of Biological Chemistry|October 5, 2012
δ-Tocopherol reduces lipid accumulation in Niemann-Pick type C1 and Wolman cholesterol storage disordersMiao Xu, Ke Liu, Manju Swaroop, et al.
Environmental Health Perspectives|November 3, 2015
Lessons from Toxicology: Developing a 21st-Century Paradigm for Medical ResearchGill Langley, Christopher P Austin, Anil K Balapure, et al.
Clinical and Translational Science|August 11, 2017
Future of Rare Diseases Research 2017-2027: An IRDiRC PerspectiveChristopher P Austin, Christine M Cutillo, Lilian P L Lau, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2007
Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activationYuli Xie, ShiXian Deng, Craig J Thomas, et al.
Scientific Reports|July 12, 2014
Profiling of the Tox21 10K compound library for agonists and antagonists of the estrogen receptor alpha signaling pathwayRuili Huang, Srilatha Sakamuru, Matt T Martin, et al.
Genomics|May 31, 2002
Melanin-concentrating hormone receptor subtypes 1 and 2: species-specific gene expressionCarina P Tan, Hideki Sano, Hisashi Iwaasa, et al.
Pageof 22